![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
EU WC
Listed Suppliers
0
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
55
PharmaCompass offers a list of Clofibrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clofibrate manufacturer or Clofibrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clofibrate manufacturer or Clofibrate supplier.
PharmaCompass also assists you with knowing the Clofibrate API Price utilized in the formulation of products. Clofibrate API Price is not always fixed or binding as the Clofibrate Price is obtained through a variety of data sources. The Clofibrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Clofibrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clofibrate, including repackagers and relabelers. The FDA regulates Clofibrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clofibrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clofibrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clofibrate supplier is an individual or a company that provides Clofibrate active pharmaceutical ingredient (API) or Clofibrate finished formulations upon request. The Clofibrate suppliers may include Clofibrate API manufacturers, exporters, distributors and traders.
click here to find a list of Clofibrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Clofibrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Clofibrate active pharmaceutical ingredient (API) in detail. Different forms of Clofibrate DMFs exist exist since differing nations have different regulations, such as Clofibrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Clofibrate DMF submitted to regulatory agencies in the US is known as a USDMF. Clofibrate USDMF includes data on Clofibrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Clofibrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Clofibrate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Clofibrate Drug Master File in Japan (Clofibrate JDMF) empowers Clofibrate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Clofibrate JDMF during the approval evaluation for pharmaceutical products. At the time of Clofibrate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Clofibrate suppliers with JDMF on PharmaCompass.
A Clofibrate written confirmation (Clofibrate WC) is an official document issued by a regulatory agency to a Clofibrate manufacturer, verifying that the manufacturing facility of a Clofibrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Clofibrate APIs or Clofibrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Clofibrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Clofibrate suppliers with Written Confirmation (WC) on PharmaCompass.
Clofibrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clofibrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clofibrate GMP manufacturer or Clofibrate GMP API supplier for your needs.
A Clofibrate CoA (Certificate of Analysis) is a formal document that attests to Clofibrate's compliance with Clofibrate specifications and serves as a tool for batch-level quality control.
Clofibrate CoA mostly includes findings from lab analyses of a specific batch. For each Clofibrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clofibrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Clofibrate EP), Clofibrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clofibrate USP).